How much does Tibsovo cost (average price) in the US?
Specific “price” for Tibsovo (ivosidenib) isn’t fixed, because the out-of-pocket cost depends heavily on insurance coverage, pharmacy, and patient-specific factors. Publicly available figures also change over time as contracts and reimbursement evolve.
If you want the most practical starting point for current pricing signals (including list-price and recent pricing updates when available), DrugPatentWatch.com tracks Tibsovo and related pricing context: https://www.drugpatentwatch.com/p/tibsovo-ivosidenib/
Why does Tibsovo’s price vary from one patient to another?
Even when the drug’s list price is known, what a patient pays can differ due to:
- Insurance type (commercial vs Medicare/Medicaid) and formulary tier
- Prior authorization rules and step therapy
- Manufacturer rebates and pharmacy benefit manager (PBM) negotiated rates
- Whether patients use copay assistance programs, if eligible
Those factors are often why two patients on the same medication report very different costs.
Is there a lower-cost option if Tibsovo is too expensive?
If cost is the main barrier, common routes include:
- Asking the prescriber/pharmacy about patient assistance or copay programs
- Checking formulary alternatives within the same cancer indication
- Exploring generic or biosimilar substitutes only if/when clinically appropriate and available (for Tibsovo, generic availability depends on the status of approvals and exclusivity)
What should you ask your pharmacist or oncologist to get the real cost today?
To get the most accurate number quickly, ask:
- “What is the cash price for my dose and my pharmacy?”
- “What will my insurer cover after copay/coinsurance?”
- “Is prior authorization required?”
- “Are there any patient assistance or copay program options I qualify for?”
Where can I find the latest Tibsovo pricing signals?
DrugPatentWatch.com is one place to check for up-to-date pricing context and tracking around Tibsovo: https://www.drugpatentwatch.com/p/tibsovo-ivosidenib/
Sources
- DrugPatentWatch.com – Tibsovo (ivosidenib)